Table 2.
Characteristics of the prevalent and incident cohorts
| Prevalent cohort (N=49,286) |
Incident cohort (N=27,224) |
|
|---|---|---|
| Age at point prevalence, mean (SD) | 70.1 (10.9) | |
| Sex, n (%) | ||
| Male | 25,142 (51.0) | 14,550 (53.0) |
| Female | 24,144 (49.0) | 12,674 (47.0) |
| Age at diagnosis, mean (SD) | 64.1 (10.8) | 67.0 (11.4) |
| Time since diagnosis (months), mean (SD) | 77.4 (65.3) | |
| Comorbidities, n (%) | ||
| Myocardial infarction | 4,127 (8.4) | 2,068 (7.6) |
| Diabetes | 9,575 (19.4) | 3,731 (13.7) |
| Hypertension | 16,994 (34.5) | 8,417 (30.9) |
| Osteoporosis | 5,696 (11.6) | 1,740 (6.4) |
| Anxiety | 1,001 (2.0) | 623 (2.3) |
| Depression | 1,452 (3.0) | 970 (3.6) |
| Smoking history, n (%) | ||
| Unknown | 6,422 (13.0) | 3,103 (11.4) |
| Current smoker | 13,550 (27.5) | 11,122 (40.9) |
| Never smoked | 4,314 (8.8) | 1,853 (6.8) |
| Ex-smoker | 25,000 (50.7) | 11,146 (40.9) |
| Maintenance therapy, n (%) | ||
| Monotherapy | 12,710 (25.8) | 13,215 (48.5) |
| Combination therapy | 27,561 (55.9) | 7,167 (26.3) |
| Patients not on any treatment | 8,987 (18.2) | 6,835 (25.1) |
Abbreviations: n, number of patients; SD, standard deviation.